Your browser is no longer supported. Please, upgrade your browser.
Settings
AXNX Axonics Modulation Technologies, Inc. daily Stock Chart
AXNX [NASD]
Axonics Modulation Technologies, Inc.
Index- P/E- EPS (ttm)-2.62 Insider Own1.80% Shs Outstand36.44M Perf Week3.80%
Market Cap1.97B Forward P/E- EPS next Y-1.22 Insider Trans-41.08% Shs Float30.96M Perf Month13.78%
Income-82.20M PEG- EPS next Q-0.52 Inst Own- Short Float19.04% Perf Quarter21.66%
Sales52.80M P/S37.30 EPS this Y-139.50% Inst Trans-2.73% Short Ratio10.96 Perf Half Y43.18%
Book/sh8.17 P/B6.11 EPS next Y36.50% ROA-36.00% Target Price52.88 Perf Year140.44%
Cash/sh7.29 P/C6.85 EPS next 5Y- ROE-44.10% 52W Range15.25 - 52.10 Perf YTD80.22%
Dividend- P/FCF- EPS past 5Y- ROI-39.60% 52W High-4.15% Beta-
Dividend %- Quick Ratio9.90 Sales past 5Y- Gross Margin55.40% 52W Low227.48% ATR2.37
Employees302 Current Ratio10.90 Sales Q/Q913.30% Oper. Margin- RSI (14)59.76 Volatility4.60% 5.04%
OptionableYes Debt/Eq0.07 EPS Q/Q20.40% Profit Margin- Rel Volume0.68 Prev Close48.52
ShortableYes LT Debt/Eq0.04 EarningsNov 04 AMC Payout- Avg Volume537.74K Price49.94
Recom1.60 SMA202.98% SMA5012.20% SMA20036.31% Volume367,271 Change2.93%
Oct-23-20Initiated Guggenheim Buy $77
Sep-02-20Initiated Robert W. Baird Outperform $52
Aug-07-20Reiterated Needham Buy $48 → $57
Jan-08-20Initiated SunTrust Buy $38
Nov-01-19Initiated Piper Jaffray Overweight $39
Oct-21-19Initiated Barclays Overweight $43
Sep-17-19Initiated SVB Leerink Outperform $45
Sep-09-19Reiterated Needham Buy $43 → $48
Sep-03-19Initiated Needham Buy $43
Jun-13-19Reiterated BofA/Merrill Buy $30 → $35
Nov-26-18Initiated Wells Fargo Outperform $22
Nov-26-18Initiated SunTrust Buy $20
Nov-26-18Initiated Morgan Stanley Overweight $21
Nov-26-18Initiated BofA/Merrill Buy $23
Oct-20-20 04:20PM  
08:00AM  
Oct-14-20 10:26AM  
06:00AM  
Oct-08-20 02:48PM  
Oct-07-20 04:00PM  
Oct-05-20 07:45PM  
08:00AM  
Sep-30-20 08:31AM  
07:36AM  
Sep-29-20 02:40PM  
10:29AM  
Sep-28-20 08:54PM  
12:20PM  
09:47AM  
Sep-24-20 06:00AM  
Sep-23-20 07:00AM  
Sep-21-20 06:00AM  
Sep-16-20 09:00AM  
Sep-10-20 06:00AM  
Sep-08-20 08:30AM  
Sep-03-20 06:00AM  
Sep-02-20 10:00AM  
Aug-10-20 09:08AM  
08:53AM  
Aug-06-20 04:00PM  
Jul-30-20 12:33PM  
Jul-27-20 06:00AM  
Jul-17-20 03:31PM  
Jul-16-20 06:00AM  
Jul-13-20 06:00AM  
Jul-01-20 04:00PM  
Jun-17-20 02:04PM  
Jun-03-20 11:29AM  
06:00AM  
May-19-20 06:00AM  
03:38AM  
May-12-20 07:00PM  
04:05PM  
May-07-20 09:14PM  
04:12PM  
09:07AM  
May-05-20 06:15PM  
04:00PM  
May-04-20 06:00AM  
Apr-29-20 06:00AM  
Apr-28-20 12:34PM  
Apr-20-20 06:41AM  
Apr-14-20 06:00AM  
Apr-08-20 06:00AM  
Apr-07-20 06:00AM  
Apr-06-20 06:00AM  
Mar-25-20 10:18AM  
Mar-16-20 06:00AM  
Mar-04-20 05:15PM  
04:01PM  
02:30PM  
Feb-26-20 12:30PM  
Feb-25-20 06:00AM  
Feb-19-20 06:00AM  
Feb-11-20 06:00AM  
Feb-04-20 06:00AM  
Jan-24-20 12:14PM  
Jan-21-20 06:00AM  
Jan-15-20 05:25AM  
Jan-09-20 06:00AM  
Dec-19-19 09:51PM  
06:00AM  
Dec-12-19 06:00AM  
Dec-09-19 06:00AM  
Dec-02-19 06:00AM  
Nov-26-19 06:00AM  
06:00AM  
Nov-25-19 06:00AM  
Nov-22-19 04:24PM  
Nov-21-19 06:00AM  
Nov-20-19 07:25AM  
Nov-19-19 09:15PM  
04:01PM  
Nov-16-19 07:44AM  
Nov-14-19 05:15PM  
04:00PM  
06:00AM  
Nov-07-19 06:00AM  
Nov-05-19 06:00AM  
Nov-04-19 04:33PM  
Nov-02-19 09:44AM  
Nov-01-19 04:28PM  
Oct-27-19 03:58PM  
Oct-15-19 06:00AM  
Oct-08-19 10:05AM  
Oct-07-19 06:00AM  
Oct-03-19 06:00AM  
Oct-02-19 06:00AM  
Sep-24-19 06:00AM  
Sep-18-19 05:54AM  
Sep-09-19 06:00AM  
Aug-27-19 06:00AM  
Aug-06-19 07:15PM  
Aug-05-19 04:00PM  
Axonics Modulation Technologies, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems in the United States and internationally. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence, and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was incorporated in 2012 and is based in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tammenoms Bakker JulietDirectorSep 18Sale42.679,167391,1193,500Sep 22 06:01 PM
Ford Alfred J JrChief Commercial OfficerSep 02Option Exercise1.4235,00049,70035,000Sep 02 07:44 PM
Ford Alfred J JrChief Commercial OfficerSep 02Sale40.2435,0001,408,2300Sep 02 07:44 PM
Ford Alfred J JrChief Commercial OfficerAug 31Sale42.312,667112,8450Sep 02 07:44 PM
Woock JohnChief Marketing OfficerAug 28Option Exercise1.4810,00014,75077,348Sep 02 08:34 AM
Woock JohnChief Marketing OfficerAug 28Sale43.4510,000434,51867,348Sep 02 08:34 AM
Tammenoms Bakker JulietDirectorAug 14Sale43.222,393103,4229,167Aug 18 05:32 PM
COHEN RAYMOND WChief Executive OfficerAug 11Sale42.1525,0001,053,636397,058Aug 11 08:32 PM
COHEN RAYMOND WChief Executive OfficerAug 07Sale41.9820,000839,583422,058Aug 11 08:32 PM
Sama RindaChief Operating OfficerAug 07Sale44.0630,0001,321,730120,001Aug 10 09:26 PM
Sama RindaChief Operating OfficerAug 06Sale43.4020,000867,918150,001Aug 10 09:26 PM
Sama RindaChief Operating OfficerJul 29Sale43.001,29255,556170,001Jul 30 09:06 PM
Sama RindaChief Operating OfficerJul 28Sale43.1013,708590,860171,293Jul 30 09:06 PM
Sama RindaChief Operating OfficerJul 21Option Exercise14.1913,127186,272199,401Jul 22 09:58 PM
Sama RindaChief Operating OfficerJul 21Sale40.8114,400587,611185,001Jul 22 09:58 PM
Sama RindaChief Operating OfficerJul 20Option Exercise5.8620,600120,782206,874Jul 22 09:58 PM
Sama RindaChief Operating OfficerJul 20Sale39.3720,600811,023186,274Jul 22 09:58 PM
COHEN RAYMOND WChief Executive OfficerJul 16Sale39.6525,000991,268442,058Jul 17 07:38 PM
COHEN RAYMOND WChief Executive OfficerJul 15Sale39.2525,000981,327467,058Jul 17 07:38 PM
COHEN RAYMOND WChief Executive OfficerJul 14Sale36.4925,000912,273492,058Jul 15 09:55 PM
COHEN RAYMOND WChief Executive OfficerJul 13Sale40.3525,0001,008,761517,058Jul 15 09:55 PM
Dearen Danny L.See RemarksJul 07Option Exercise1.637091,15657,200Jul 09 06:22 PM
Dearen Danny L.See RemarksJul 07Sale40.0070928,36056,491Jul 09 06:22 PM
Dearen Danny L.See RemarksJun 22Option Exercise1.5645,00070,171101,491Jun 22 09:58 PM
Dearen Danny L.See RemarksJun 22Sale38.1145,0001,714,97756,491Jun 22 09:58 PM
Dearen Danny L.See RemarksJun 18Option Exercise1.4130,00042,37586,491Jun 22 09:58 PM
Dearen Danny L.See RemarksJun 18Sale39.2630,0001,177,88156,491Jun 22 09:58 PM
Dearen Danny L.See RemarksMay 19Option Exercise1.3215,00019,80071,491May 19 09:01 PM
Dearen Danny L.See RemarksMay 19Sale40.0515,000600,77756,491May 19 09:01 PM
Sama RindaChief Operating OfficerMay 19Sale39.0020780186,274May 21 09:34 PM
Dearen Danny L.See RemarksMay 18Option Exercise1.3215,00019,80071,491May 19 09:01 PM
Dearen Danny L.See RemarksMay 18Sale37.2615,000558,84256,491May 19 09:01 PM
Dearen Danny L.See RemarksMay 15Option Exercise1.0130,00030,32586,491May 19 09:01 PM
Dearen Danny L.See RemarksMay 15Sale35.1330,0001,053,99356,491May 19 09:01 PM
Dearen Danny L.See RemarksMay 14Option Exercise0.9820,00019,60076,491May 14 09:58 PM
Dearen Danny L.See RemarksMay 14Sale34.1920,000683,70756,491May 14 09:58 PM
Dearen Danny L.See RemarksMay 11Option Exercise0.9830,00029,40086,491May 14 09:58 PM
Dearen Danny L.See RemarksMay 11Sale34.8630,0001,045,94356,491May 14 09:58 PM
Sama RindaChief Operating OfficerApr 30Sale32.205,000161,015186,294May 04 07:28 PM
Sama RindaChief Operating OfficerApr 02Sale23.725,000118,600191,294Apr 06 05:17 PM
COHEN RAYMOND WChief Executive OfficerMar 16Option Exercise1.6341,22467,195583,282Mar 18 06:00 PM
COHEN RAYMOND WChief Executive OfficerMar 16Sale20.9741,224864,639542,058Mar 18 06:00 PM
Sama RindaChief Operating OfficerMar 05Sale38.125,000190,600196,294Mar 09 09:13 PM
Dearen Danny L.See RemarksMar 02Option Exercise0.984,1474,06412,682Mar 04 08:54 PM
Dearen Danny L.See RemarksMar 02Sale37.004,147153,4398,535Mar 04 08:54 PM
Dearen Danny L.See RemarksFeb 26Option Exercise0.988,0007,84024,388Feb 28 09:49 PM
Dearen Danny L.See RemarksFeb 26Sale37.0115,853586,6748,535Feb 28 09:49 PM
Woock JohnChief Marketing OfficerFeb 25Option Exercise1.6310,00016,30077,348Feb 27 09:05 PM
Woock JohnChief Marketing OfficerFeb 25Sale35.8710,000358,72667,348Feb 27 09:05 PM
Dearen Danny L.See RemarksFeb 18Sale34.2520,000685,00016,388Feb 18 08:32 PM
COHEN RAYMOND WChief Executive OfficerFeb 13Option Exercise1.6310,00016,300552,058Feb 18 08:32 PM
Dearen Danny L.See RemarksFeb 13Sale34.001033,50236,388Feb 18 08:32 PM
COHEN RAYMOND WChief Executive OfficerFeb 13Sale33.2110,000332,065542,058Feb 18 08:32 PM
Sama RindaChief Operating OfficerFeb 06Sale29.145,000145,689201,294Feb 11 04:23 PM
COHEN RAYMOND WChief Executive OfficerJan 30Option Exercise0.0016,6670625,058Feb 03 09:06 PM
Woock JohnChief Marketing OfficerJan 30Option Exercise0.002,667067,348Feb 03 09:03 PM
Sama RindaChief Operating OfficerJan 30Option Exercise0.005,6670206,294Feb 03 09:03 PM
Ford Alfred J JrChief Commercial OfficerJan 30Option Exercise0.002,66702,667Feb 03 09:04 PM
Dearen Danny L.See RemarksJan 30Option Exercise0.008,000036,491Feb 03 09:04 PM
Woock JohnChief Marketing OfficerJan 28Sale30.0615,000450,83764,681Jan 30 08:01 PM
Dearen Danny L.See RemarksJan 23Sale31.4620,000629,15628,491Jan 27 08:53 PM
Wisniewski RaphaelDirectorJan 22Sale31.54135,2614,266,3892,957,461Jan 22 09:19 PM
Andera Partners10% OwnerJan 22Sale31.54135,2614,266,3892,957,461Jan 22 09:20 PM
Andera Partners10% OwnerJan 17Sale31.51164,7395,191,4863,092,722Jan 22 09:20 PM
Wisniewski RaphaelDirectorJan 17Sale31.51164,7395,191,4863,092,722Jan 22 09:19 PM
COHEN RAYMOND WChief Executive OfficerJan 13Option Exercise1.6310,00016,300618,391Jan 16 05:31 PM
COHEN RAYMOND WChief Executive OfficerJan 13Sale31.9810,000319,800608,391Jan 16 05:31 PM
Sama RindaChief Operating OfficerJan 02Sale27.425,000137,105200,627Jan 06 08:30 PM
Dearen Danny L.See RemarksDec 19Sale26.0730,000782,10948,491Dec 23 05:56 PM
Sama RindaChief Operating OfficerDec 05Sale23.925,000119,620205,627Dec 09 05:27 PM
Woock JohnChief Marketing OfficerDec 02Sale23.4615,000351,88279,681Dec 04 08:13 PM
Andera Partners10% OwnerNov 22Sale20.74300,0006,220,5003,257,461Nov 26 09:07 PM
Dearen Danny L.See RemarksNov 21Sale21.6130,000648,22578,491Nov 25 04:08 PM
Wisniewski RaphaelDirectorNov 19Sale20.74300,0006,220,5003,257,461Nov 22 07:29 AM
COHEN RAYMOND WChief Executive OfficerNov 19Sale20.7475,0001,555,125608,391Nov 21 08:42 PM
Dearen Danny L.See RemarksNov 19Sale20.7430,000622,050108,491Nov 21 08:42 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.